Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07416695RecruitingPhase 1
Study of HLX3901 for advanced lung or neuroendocrine cancer
This trial tests a new drug, HLX3901, for people with advanced small cell lung cancer or neuroendocrine cancer that has worsened after previous treatments. The goal is to see if it's safe and how the body handles it.
BeijingAges 18–75 - NCT07453082Recruiting
A study on miRNA371 for newly diagnosed germ cell tumors
This study is looking at a new marker called miRNA371 in people newly diagnosed with germ cell tumors. The goal is to see if it can help predict relapse and guide treatment decisions.
Candiolo, TurinAges 18 years+ - NCT07404787Recruiting
Suicide prevention telehealth program for soldiers after hospital stay
This trial tests a telehealth case management program to help prevent suicide among soldiers recently discharged from a psychiatric hospital. If you are an active duty soldier who has been hospitalized for mental health reasons and have access to a phone and computer, this program may provide extra support during your recovery.
Bethesda, MarylandAges 18 years+ - NCT06609603Recruiting
Study on green tea extract for reducing body fat
This study tests whether a special heat-treated green tea extract can help reduce body fat in people with overweight or obesity. It involves taking the extract daily for a period and checking changes in your body composition.
Suwon, Gyeonggi-doAges 19–64 - NCT07449039Recruiting
Blood sugar tracking after pregnancy for diabetes risk
This study uses a continuous glucose monitor to track blood sugar for 2 weeks after delivery in women who had gestational diabetes. The goal is to better understand who develops type 2 diabetes later and help prevent it.
Los Angeles, CaliforniaAges 18 years+ - NCT06639828RecruitingPhase 4
Safety study of Sonazoid for liver ultrasound in children
This trial tests a contrast agent called Sonazoid, which is used during an ultrasound to get clearer pictures of the liver. It is for children and teens who have one or more spots in the liver that need to be checked. The goal is to see if Sonazoid is safe and works well for children.
MünchenAges Up to 18 years - NCT06774300Recruiting
Video-based alcohol help for college students
This study tests whether a brief alcohol check-in and advice session, done over video call, works well for college students. It aims to help students who binge drink and want to cut down or avoid more drinking-related problems.
Houston, TexasAges 18–26 - NCT06590753Recruiting
Comparing two implant methods for lower denture support
This study compares two different ways of placing dental implants to hold a lower denture (overdenture). One method is a newer 'osseodensification' technique that helps make the bone denser around the implant, while the other is the standard drilling approach. The goal is to see which method gives better results for people who need a stable, implant-supported denture.
CairoAges 55–65 - NCT06450093Recruiting
Comparing three crown types for baby teeth
This study compares three types of crowns (BioFlx, zirconia, and stainless steel) placed on lower baby molars that have cavities. It aims to find which crown works best for children, focusing on how easy they are to place and how well they hold up over time.
Al Mansurah, Dakahlia GovernorateAges 4–7 - NCT06601075Recruiting
FDG and FAPI PET Scans for Advanced Colorectal Cancer
This trial uses two types of PET/CT scans (FDG and FAPI) to better see and track colorectal cancer that has spread to the belly lining (peritoneum). It aims to help doctors choose the best treatment by improving how they detect and monitor the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06598930Recruiting
Nurse-led follow-up after mild lung blood clot
This study compares two ways of following up after a non-severe pulmonary embolism: standard medical care alone versus intensive monitoring that includes an advanced practice nurse. The goal is to see if the nurse-led follow-up improves your recovery and quality of life.
DijonAges 18 years+ - NCT07018947RecruitingPhase 2
Atezolizumab and bevacizumab before and after surgery for liver cancer
This trial tests whether adding two drugs (atezolizumab and bevacizumab) before and after surgery can lower the chance of liver cancer coming back in people with high-risk HCC. You must be eligible for surgical removal of your tumor.
Badalona, BarcelonaAges 18 years+ - NCT07080008RecruitingPhase 1
Seeing the ureters during belly or pelvic surgery
This trial tests a dye called Lumitrace that helps surgeons see the tubes connecting your kidneys to your bladder (ureters) during minimally invasive surgery in the belly or pelvis. It might help prevent accidental injury to these tubes during the operation.
Kansas City, MissouriAges 18 years+ - NCT06450171Recruiting
Multi-cancer early detection test for people at high risk
This study tests a blood-based multi-cancer early detection (MCED) screening test in people with a high risk of cancer due to inherited gene changes or strong family history. The goal is to see if this test can find cancer early.
Boston, MassachusettsAges 22 years+ - NCT07146165Recruiting
New tool for removing large growths in the rectum and lower colon
This trial tests a new platform to help doctors remove large polyps or early-stage cancers from the rectum and lower colon using a scope (endoscope). The goal is to see if this tool makes the removal process safer and more effective.
Freiburg im BreisgauAges 18 years+ - NCT07027605Recruiting
Testing a computer tool for colorectal liver metastasis prognosis
This trial is testing a computer program that helps doctors predict outcomes for people with colorectal cancer that has spread to the liver. It is for patients who have had surgery to remove both the colon and liver tumors.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06958679RecruitingPhase 1
Study of SYS6005 for advanced solid tumors and lymphomas
This study tests a new drug (SYS6005) that targets a protein called ROR1 on certain cancer cells. It is for people with advanced solid tumors or B-cell lymphomas that have stopped responding to other treatments.
TianjinAges 18 years+ - NCT07073664Enrolling by invitation
Endoscopic sinus expansion plus Stapokibart for chronic sinusitis
This trial tests if a new drug (Stapokibart) combined with a sinus surgery improves symptoms like nasal congestion, discharge, and loss of smell in people with type 2 chronic sinusitis.
Changchun, JilinAges 18–75 - NCT06592365Recruiting
Green tea extract for blood sugar control
This trial tests whether a green tea extract can help regulate blood sugar levels in people with mildly elevated fasting glucose. If you are between 19 and 64, have a BMI under 30, and have not been diagnosed with diabetes, you may be able to join.
SeoulAges 19–64 - NCT07146464Recruiting
Peptide vs calcium paste for early cavity spots
This trial tests whether a new peptide treatment or a calcium-phosphate paste works better at reversing early white-spot cavities on front teeth. If you're a young adult with early decay on your front teeth, you may be able to join.
Cairo, Cairo GovernorateAges 15–25 - NCT06636552RecruitingPhase 2
Alternating drug combo plus daratumumab for newly diagnosed plasma cell leukemia
This trial tests a new treatment plan for people newly diagnosed with primary plasma cell leukemia (pPCL). It uses two different drug combinations that include daratumumab, given one after the other, followed by maintenance daratumumab. The goal is to see if this approach is safe and works well.
Athens, AtticaAges 18–80 - NCT07449377Recruiting
Can a liver scan help diagnose heart failure in the ER?
This study tests whether a quick, non-invasive liver scan (Fibroscan) can help diagnose heart failure in people who come to the emergency department with sudden shortness of breath.
ParisAges 18 years+ - NCT06889896Enrolling by invitation
Blood test for Alzheimer's brain changes
This study uses a simple blood test to quickly detect Alzheimer's-related brain changes (amyloid plaques). It may help people with memory concerns avoid a more invasive PET scan and get answers faster.
Hefei, AnhuiAges 45–85 - NCT07147114RecruitingPhase 4
Combined macitentan and dapagliflozin for heart failure with lung high blood pressure
This trial tests whether adding two medications—macitentan and dapagliflozin—together is safe and effective for people with heart failure and a certain type of high blood pressure in the lungs. It might help improve your symptoms and daily function.
BusanAges 19 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.